Niagen Bioscience Sponsors Inaugural NAD for Health Conference

The University of Copenhagen hosts the event focused on the science of NAD+ and healthy aging.

Feb. 9, 2026 at 7:55am

Got story updates? Submit your updates here. ›

Niagen Bioscience, a global leader in NAD+ research, has announced it is the premiere sponsor of the inaugural 'NAD for Health: Opportunities & Challenges' conference hosted by the University of Copenhagen. The three-day event, taking place March 23-25, 2026, will bring together researchers, clinicians, and industry partners to discuss the latest advances in NAD biology and its therapeutic potential.

Why it matters

NAD+ is a vital coenzyme that declines with age, contributing to various age-related health issues. This conference aims to align the research community on standards, resources, and collaboration needed to translate NAD science into meaningful health outcomes.

The details

The conference will feature thematic sessions, a panel discussion, and a poster session showcasing early-career researcher presentations. Key topics include NAD+ precursor strategies for rare diseases, interventions to improve healthspan, and NAD-boosting approaches for neurodegenerative diseases. The panel discussion will be livestreamed globally.

  • The conference will take place from March 23-25, 2026.
  • Registration is required by February 15, 2026.

The players

Niagen Bioscience

A global leader in NAD+ science and healthy-aging research, serving as the premiere sponsor of the conference.

University of Copenhagen

The host institution for the inaugural 'NAD for Health: Opportunities & Challenges' conference.

Jonas Treebak, PhD

Associate Professor at the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen, and one of the conference organizers.

Vilhelm (Will) Bohr, MD, PhD

Affiliate Professor in Genome Instability and Neurodegeneration at the University of Copenhagen, and one of the conference organizers.

Andrew Shao, PhD

Senior Vice President of Regulatory and Scientific Affairs at Niagen Bioscience.

Got photos? Submit your photos here. ›

What they’re saying

“Advancing NAD science requires more than promising data—it requires rigorous dialogue across disciplines, clear translational standards, and alignment on what meaningful outcomes look like.”

— Andrew Shao, Senior Vice President of Regulatory and Scientific Affairs

“This meeting was designed to convene the people generating the most important new insights in NAD biology—and to do it in a setting that encourages candid, evidence-based discussion.”

— Jonas Treebak, Associate Professor

“NAD+ is central to metabolism, mitochondrial functions, DNA repair, cellular resilience, and aging biology, and the field is advancing rapidly.”

— Vilhelm (Will) Bohr, Affiliate Professor

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

This conference emphasizes the importance of aligning the research community on standards, resources, and collaboration to translate NAD science into meaningful health outcomes and advance the understanding of NAD+ and its role in healthy aging.